Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003167 · ClinicalTrials.gov registry record · NA
Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05003167: Completed NA study, sponsored by Purdue University.
NCT05003167 is a NA study that has completed, run by Purdue University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05003167, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.
Primary Outcome
Change in expiratory muscle strength throughout the study duration measured by the participant blowing into a pressure meter
Interventions
- DEVICE Expiratory Muscle Strength Training (EMST-150)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT05003167 record still lists
NCT05003167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Expiratory Muscle Strength Training (EMST-150) is the first listed.
NCT05003167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05003167 about?
NCT05003167 is a clinical study titled "Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS". A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of the...
What is the current status of trial NCT05003167?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-01-01. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05003167?
The interventions under investigation include: Expiratory Muscle Strength Training (EMST-150) (DEVICE).
Who is sponsoring clinical trial NCT05003167?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05003167's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI